Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Alzheimers Dement. 2019 Jan 11;15(4):561–569. doi: 10.1016/j.jalz.2018.10.008

Table 2.

Baseline demographic and clinical characteristics [mean (SD) or %] by group.

CN
(N=420)
MCI
(N=788)
p-value
Age 74.70 (5.76) 73.18 (7.54) <.001
Education 16.34 (2.67) 15.99 (2.81) .036
Female, % 48.9% 40.8% .007
GDS 0.76 (1.08) 1.68 (1.43) <.001
MMSE 29.07 (1.14) 27.61 (1.80) <.001
CDR=0.5, % 0.5% 99.7% <.001
CDR Memory=0.5, % 0.6% 96.9% <.001
FAQ 0.22 (0.94) 3.14 (4.06) <.001
Logical Memory II (raw) 13.16 (3.30) 5.68 (3.42) <.001
AVLT delayed recall (raw) 7.56 (3.89) 3.90 (3.86) <.001
1352.57 (659.56) 1013.88 (553.69) <.001
p-tau/Aβ 0.02 (0.02) 0.04 (0.03) <.001
t-tau/Aβ 0.23 (0.18) 0.36 (0.27) <.001
p-tau 21.70 (8.91) 27.81 (14.19) <.001
t-tau 236.39 (87.09) 287.19 (126.30) <.001
APOE ε4+, % 27.6% 51.1% <.001

Note. CN=Cognitively Normal; MCI=Mild Cognitive Impairment; GDS=Geriatric Depression Scale; MMSE=Mini-Mental State Exam; CDR=Clinical Dementia Rating; FAQ=Functional Activities Questionnaire; AVLT=Rey Auditory Verbal Learning Test; Aβ= β-amyloid; p-tau=hyperphosphorylated tau; t-tau=total tau APOE=Apolipoprotein E. For the CSF markers, the CN group had n=289 and MCI group had n=581.